52North-preview

52north

52North

Private

CambridgeHealthcare & Life Scienceshttps://52north.health

Last Round

Series A

Dec 3, 2024

Total Funding Raised

$10.22M

Momentum Score

25 /100

Company Overview

52North is a medical technology company that develops in-vitro diagnostic and digital solutions to transform patient journeys in urgent care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Defense Tech, Sensors, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Hardware Sales

AI Layer

Application

Keywords

point-of-care diagnosticsneutropenic sepsisat-home monitoringremote patient monitoringRPMoncology diagnosticsAI-driven triagefinger-prick blood testmedtechPoC testingremote triagedual-use technologyportable diagnosticsacute radiation syndromebiomarker analysismedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

52North Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

52North Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 3, 2024
Grant	Dec 3, 2024
Grant	Nov 22, 2022
Seed	Apr 28, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Joe Neale

Chief Technology Officer

Executive Team

Rebecca Simmons

Chief Operating Officer

Executive Team

52North Investors

Notable investors and investment history

Investor	Rounds
Innovate UK	Grant
Cancer Research Horizons	Series A
Milltrust Ventures	Seed
OKG Capital	Series A
Cambridge Enterprise	Seed
Crista Galli Ventures	Seed
Macmillan Cancer Support	Series A

View all Investors

52North Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

52North Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 52North's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range26

Year Founded2018

Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.